Published in Arch Dermatol Res on January 01, 1994
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Psoriasis, T cells and autoimmunity. J R Soc Med (1996) 1.19
Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12
Immuno-inflammatory cell dynamics during cutaneous wound healing. J Anat (1999) 0.94
Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats. Am J Pathol (1995) 0.77
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol (1990) 3.77
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol (1998) 3.38
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (1993) 2.63
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol (1998) 2.30
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol (1999) 2.03
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today (1991) 1.89
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol (1999) 1.73
Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol (2010) 1.68
Sudden unexpected death in young adults. Discrepancies between initiation of acute plaque complications and the onset of acute coronary death. Eur Heart J (2002) 1.68
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol (2001) 1.65
Human atopen-specific types 1 and 2 T helper cell clones. J Immunol (1991) 1.62
Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol (1990) 1.62
Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol (1990) 1.59
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br J Dermatol (2007) 1.55
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol (2004) 1.53
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol (1997) 1.46
Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies. Arch Dermatol Res (1983) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem (1999) 1.44
Endothelial insulin receptor expression in human atherosclerotic plaques: linking micro- and macrovascular disease in diabetes? Atherosclerosis (2012) 1.41
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
Activation of complement in psoriasis. Clin Exp Dermatol (1998) 1.39
Neopterin, immune activation, and psoriasis. Lancet (1991) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol (1991) 1.30
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res (1989) 1.29
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol (1993) 1.28
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol (2001) 1.24
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23. Exp Dermatol (2004) 1.19
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol (1998) 1.16
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol (1998) 1.13
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res (1999) 1.13
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. Br J Dermatol (2006) 1.10
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
Treponemicidal levels of amoxicillin in cerebrospinal fluid after oral administration. Sex Transm Dis (1984) 1.10
The mosquito problem and type and costs of personal protection measures used in rural and urban communities in Pondicherry region, South India. Acta Trop (2003) 1.10
Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Trans R Soc Trop Med Hyg (1996) 1.09
Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol (2008) 1.08
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol (1993) 1.08
Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol (2009) 1.08
The role of lymphoid cells and polymorphonuclear leukocytes in the pathogenesis of psoriasis. J Dermatol (1976) 1.07
Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control. Epidemiol Infect (1989) 1.07
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface. Infect Immun (1992) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy (2011) 1.05
Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion. Biochem J (1999) 1.04
Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am J Pathol (1992) 1.04
The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology (1998) 1.04
Diversity and divergence among the tribal populations of India. Ann Hum Genet (2005) 1.04
The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology (2004) 1.03
Causes, investigation and treatment of leg ulceration. Br J Dermatol (2003) 1.03
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Control of malaria and filariasis vectors in South India. Parasitol Today (1987) 1.03
Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. Ann Rheum Dis (2004) 1.03
The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med (1998) 1.03